DOBRINA, ALDO
 Distribuzione geografica
Continente #
NA - Nord America 5.874
EU - Europa 2.389
AS - Asia 2.352
SA - Sud America 306
AF - Africa 101
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.034
Nazione #
US - Stati Uniti d'America 5.828
SG - Singapore 843
PL - Polonia 662
CN - Cina 640
UA - Ucraina 440
SE - Svezia 299
HK - Hong Kong 269
BR - Brasile 247
IT - Italia 221
VN - Vietnam 220
FI - Finlandia 151
FR - Francia 126
KR - Corea 123
GB - Regno Unito 106
DE - Germania 87
RU - Federazione Russa 87
TR - Turchia 87
MA - Marocco 74
BG - Bulgaria 68
IE - Irlanda 68
IN - India 39
JP - Giappone 19
MX - Messico 19
CH - Svizzera 18
AR - Argentina 17
CA - Canada 16
BD - Bangladesh 14
IQ - Iraq 14
SA - Arabia Saudita 14
BE - Belgio 13
EC - Ecuador 12
NL - Olanda 12
ZA - Sudafrica 11
ID - Indonesia 10
AU - Australia 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
PH - Filippine 7
PK - Pakistan 6
DZ - Algeria 5
IL - Israele 5
IR - Iran 5
KZ - Kazakistan 5
MY - Malesia 5
RO - Romania 5
ES - Italia 4
AT - Austria 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
EG - Egitto 3
GR - Grecia 3
KE - Kenya 3
LT - Lituania 3
PA - Panama 3
PE - Perù 3
PY - Paraguay 3
UY - Uruguay 3
CL - Cile 2
CZ - Repubblica Ceca 2
EU - Europa 2
JO - Giordania 2
KW - Kuwait 2
MD - Moldavia 2
MN - Mongolia 2
NP - Nepal 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
MG - Madagascar 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 11.034
Città #
Woodbridge 716
Fairfield 603
Warsaw 591
Singapore 504
Ashburn 493
Ann Arbor 485
Houston 449
Jacksonville 385
Wilmington 334
Chandler 308
Hong Kong 265
Seattle 262
San Jose 221
Cambridge 218
Hefei 156
Princeton 132
Beijing 125
Seoul 121
Boardman 107
Chicago 87
Izmir 82
Santa Clara 78
Casablanca 69
Dublin 68
Sofia 68
Zgierz 66
Columbus 64
Ho Chi Minh City 63
Lauterbourg 59
Trieste 59
Hanoi 58
Los Angeles 51
Moscow 43
Buffalo 42
Dearborn 35
Milan 35
Frankfurt am Main 32
Dallas 31
The Dalles 29
San Diego 27
São Paulo 23
Falls Church 21
Munich 21
Düsseldorf 20
Jinan 18
Nanjing 17
Washington 16
London 15
Des Moines 14
Phoenix 14
Brussels 13
Guangzhou 13
Turku 13
Bern 12
Tokyo 12
Verona 12
New York 11
Shenyang 11
Tianjin 11
Helsinki 10
Norwalk 10
Council Bluffs 9
Jersey City 9
Kunming 9
Orem 9
Brooklyn 8
Da Nang 8
Denver 8
Hebei 8
Shanghai 8
Belo Horizonte 7
Montreal 7
Nanchang 7
Quito 7
Shenzhen 7
Atlanta 6
Auburn Hills 6
Dong Ket 6
Haiphong 6
Hangzhou 6
Johannesburg 6
Long Branch 6
Paris 6
Stockholm 6
Campinas 5
Fuzhou 5
Indiana 5
Nuremberg 5
Poplar 5
Portsmouth 5
Rio de Janeiro 5
Salvador 5
Secaucus 5
Tappahannock 5
Amsterdam 4
Brasília 4
Can Tho 4
Cardiff 4
Dubai 4
Goiânia 4
Totale 8.167
Nome #
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 421
Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes. 411
Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse. 390
Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. 236
Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation. 235
Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction. 224
Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase 214
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction 210
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 204
Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction. 198
Disorders of neutrophil functions 198
Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo 195
Effects of endotoxin in mice bearing solid metastasizing tumors and treated with lysozyme hydrochloride 194
Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. 194
Widespread myocardial inflammation and infarct-related artery patency. 189
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 188
Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction. 185
Complement-endothelial cell interactions: pathophysiological implications. 180
Effect of acylated flavonoids on neutrophil adherence to endothelial cells. 178
Soluble interleukin-2 receptor: is there a role in ischaemic cardiomyopathy? 175
High-risk clinical features predict increased post-infarction myocardial apoptosis and the benefits as a result of an open infarct-related artery. 173
Apoptosis and post-infarction left ventricular remodeling. 172
Complement-endothelial cell interactions: pathophysiological implications. 170
Heterogeneity of macrophages as revealed by studies on their oxidative metabolism 169
Inhibition of neutrophil adherence to vascular endothelial cells a new acylated flavonoid. 167
Right ventricular dilatation after left ventricular acute myocardial infarction is predictive of extremely high peri-infarctual apoptosis at postmortem examination in humans. 167
Interaction between chronically HIV-infected promonocytic cells and human umbilical vein endothelial cells: role of proinflammatory cytokines and chemokines in viral expression modulation. 166
Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance 159
Cirrhotic cardiomyopathy. 155
Prostacyclin in sepsis: a systematic review. 152
Effects of acylated flavonoids on neutrophil adherence to endothelial cells 150
Hemodynamic effects of a prostacyclin analog (iloprost) on portal flow velocity and volume and visceral artery circulation in patients with lower limb arteriopathy. 150
Multiple receptors on human monocytes are involved in adhesion to cultured human endothelial cells. 149
New therapeutic approaches to liver fibrosis: a practicable route? 148
Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients. 147
Iloprost: an adjunctive approach to chronic viral hepatitis treatment. 147
Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. 146
CD11/CD18-independent neutrophil adherence to inducible endothelial-leucocyte adhesion molecules (E-LAM) in vitro. 146
Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. 144
Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention. 140
Metabolic properties of freshly isolated bovine endothelial cells. 135
Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. 133
Complement-endothelial cell interaction: pathophysiological implications. 132
Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes 132
Prostacyclin in liver disease: a potential therapeutic option. 131
The respiratory burst and endothelial cells 129
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications. 128
Identification and partial characterization of a cytolytic toxin produced by Gardnerella vaginalis. 128
Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. 127
Phorbol ester causes down-regulation of CD11/CD18-independent neutrophil adherence to endothelium. 124
Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting. 118
Enhanced portal flow velocity and volume following Iloprost treatment 117
Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease. 116
Biological activity of a peptidoglycan extracted from Leptospira interrogans: in vitro studies. 116
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis. 115
Leptospira interrogans and Leptospira peptidoglycans induce the release of tumor necrosis factor alpha from human monocytes. 115
Postmeal portal flow variations in HCV-related chronic hepatitis and liver cirrhosis with and without hyperdynamic syndrome. 111
null 108
Isolation of metabolically active endothelial cells in high yield from bovine cavernous bodies. A model for functional studies on freshly isolated microvascular endothelial cells. 108
null 101
null 101
[Mediastinal lymphangioma (with a report on 3 personal cases)]. 99
null 96
The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. 93
Inhibition of netrophil adherence to vascular endothelial cells by a new acylated flavonoid. 88
Leptospira icterohemorrhagiae and leptospire peptidoglycans induce endothelial cell adhesiveness for polymorphonuclear leukocytes 83
null 80
TUMOR NECROSIS FACTOR-ALPHA EXHIBITS GREATER PROINFLAMMATORY ACTIVITY THAN LYMPHOTOXIN IN VITRO. 76
Neutrophil-endothelial cell interaction:evidence for and mechanisms of bovine microvascular endothelial cells self protection from hydrogen peroxide-induced oxidative stress 73
null 67
null 64
High-Risk clinical increased post-infarction myocardial apoptosis and the benefits as a result of an open infarct-related artery 63
null 61
Mechanisms of eosinophil adherence to cultured vascular endothelial cell. Eosinophils bind to the cytokine-induced endothelial ligand Vascular Cell Adhesion Molecule-1 via the Very Late Activation antigen-4 integrin receptor. 50
null 48
Totale 11.302
Categoria #
all - tutte 31.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.641


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021252 0 0 0 0 0 0 0 0 0 111 36 105
2021/2022737 30 41 26 51 12 61 24 32 83 70 81 226
2022/2023916 81 85 62 138 95 171 17 55 156 2 40 14
2023/2024532 38 31 27 27 62 67 99 97 5 11 29 39
2024/20251.004 18 16 54 83 169 89 89 59 103 108 92 124
2025/20262.615 146 193 244 375 247 282 438 104 288 298 0 0
Totale 11.302